Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
09:22:25 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.165 USD | -1.71% |
|
-0.47% | +15.09% |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| 11/08 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
| Market Cap | 37Cr 32Cr 30Cr 27Cr 51Cr 3.51TCr 52Cr 348.98Cr 136.75Cr 1.76TCr 138Cr 135.01Cr 5.86TCr | P/E 2026 * |
-3.14x | P/E 2027 * | -2.91x |
|---|---|---|---|---|---|
| Enterprise Value | 20Cr 17Cr 16Cr 15Cr 28Cr 1.92TCr 28Cr 190.85Cr 75Cr 962.91Cr 75Cr 74Cr 3.2TCr | EV / Sales 2026 * |
599x | EV / Sales 2027 * | 345x |
| Free-Float |
89.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | -2.33% | ||
| 1 week | -0.16% | ||
| Current month | +9.11% | ||
| 1 month | +8.73% | ||
| 3 months | -15.56% | ||
| 6 months | -36.88% | ||
| Current year | +15.45% |
| 1 week | 3.03 |  | 3.3 |
| 1 month | 2.69 | | 3.3 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 05/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 04/09/2025 |
Paul Lyne
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 05/02/2023 |
Lori Woods
CHM | Chairman | 63 | 03/02/2023 |
| Director/Board Member | 60 | 05/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/03/26 | Free | Director | 50,000 | 0.0439% | ||
| 13/11/25 | Buy | Controller/Auditor | 11,000 | 0.0148% | ||
| 12/11/25 | Buy | Director | 9,498 | 0.0128% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.64% | -0.16% | -13.96% | -22.75% | 37Cr | |
| -0.04% | -1.67% | +1.80% | +19.90% | 4.88TCr | |
| -0.33% | +3.42% | +483.22% | +617.71% | 4.54TCr | |
| +1.13% | +2.03% | +14.80% | +89.89% | 4.12TCr | |
| +1.17% | -0.06% | +26.57% | +13.89% | 3.97TCr | |
| -0.50% | 0.00% | +20.60% | +60.49% | 3.26TCr | |
| +1.17% | -1.54% | - | - | 1.62TCr | |
| -0.73% | -1.82% | +28.42% | +138.10% | 1.67TCr | |
| -0.23% | -0.09% | +3.71% | +29.48% | 1.41TCr | |
| -0.07% | +1.90% | +83.05% | +44.47% | 1.37TCr | |
| Average | -0.03% | +0.75% | +72.02% | +110.13% | 2.69TCr | |
| Weighted average by Cap. | +0.26% | +0.04% | +103.08% | +152.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 3L 3L 2L 5L 3.21Cr 5L 31.85L 12.48L 1.61Cr 12.59L 12.32L 5.35Cr | 4L 3L 3L 3L 5L 3.79Cr 6L 37.61L 14.74L 1.9Cr 14.87L 14.55L 6.31Cr |
| Net income | -12Cr -9.95Cr -9.33Cr -8.5Cr -16Cr -1.1TCr -16Cr -109.41Cr -43Cr -552.01Cr -43Cr -42Cr -1.84TCr | -14Cr -12Cr -11Cr -10Cr -19Cr -1.31TCr -19Cr -130.11Cr -51Cr -656.44Cr -51Cr -50Cr -2.18TCr |
| Net Debt | -17Cr -14Cr -13Cr -12Cr -23Cr -1.59TCr -23Cr -158.13Cr -62Cr -797.82Cr -63Cr -61Cr -2.65TCr | -23Cr -20Cr -19Cr -17Cr -32Cr -2.21TCr -32Cr -219.19Cr -86Cr -1.11TCr -87Cr -85Cr -3.68TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $3.165 | -1.71% | 2,56,360 |
| 17/26/17 | $3.220 | +0.63% | 11,68,261 |
| 14/26/14 | $3.200 | +3.23% | 10,00,183 |
| 13/26/13 | $3.100 | -4.91% | 13,18,924 |
| 12/26/12 | $3.260 | +2.52% | 11,85,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
